AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue

Navigation

Page 40 of 43

41 9.3. Pregnancy in Patients With HCM COR LOE Recommendations 2a C-LD 8. In pregnant women with HCM, general or epidural anesthesia is reasonable, with precautions to avoid hypotension. 2a C-EO 9. In pregnant women with HCM, it is reasonable to perform serial echocardiography, particularly during the second or third trimester when hemodynamic load is highest, or if clinical symptoms develop. 2b C-EO 10. In pregnant women with HCM, fetal echocardiography may be considered for diagnosis of fetal HCM in the context of prenatal counseling. 3: Harm C-EO 11. In pregnant women, use of mavacamten is contraindicated due to potential teratogenic effects. 9.4. Patients With Comorbidities COR LOE Recommendations 1 C-EO 1. In patients with HCM, adherence to the ACC/AHA primary prevention guideline is recommended to reduce risk of cardiovascular events. 1 B-NR 2. In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are recommended for achieving and maintaining weight loss and possibly lowering the risk of developing LVOTO, HF, and AF. 1 C-LD 3. In patients with HCM and hypertension, lifestyle modifications and medical therapy for hypertension are recommended, with preference for beta blockers and nondihydropyridine calcium channel blockers in patients with obstructive HCM. 1 C-LD 4. In patients with HCM, assessment for symptoms of sleep- disordered breathing is recommended and, if present, referral to a sleep medicine specialist for evaluation and treatment is recommended. (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024